Viking Systems raises $934,897 through sale of common stock

NewsGuard 100/100 Score

Viking Systems Inc. (OTCBB:VKNG) announced today that it has increased its cash and liquidity position through the issuance of common stock. The Company raised $934,897 by selling an aggregate of 4,398,050 shares of its common stock through its previously announced financing facility with Dutchess Opportunity Fund, II, LP.

Robert Mathews, Executive Vice President and CFO of Viking Systems, Inc. said, "We are very pleased to announce that we have brought significant capital into the Company. Clearly it is very important to have access to capital to fund our strategic plans. We have made great progress towards launching our Next Generation 3DHD System and it is essential to have the financial means to fund the final phases of this effort."

The Company has previously stated, and again reiterated, that it intends to raise a total of $2 million to $3 million during 2010 to fund the development and launch of its Next Generation 3DHD system, anticipated 2010 operating losses and working capital needs.

The Company plans to launch its "Next Generation" 3DHD System in the fourth quarter of 2010. The system is targeted to provide the highest quality 3DHD visualization in a cost effective, standalone solution available for minimally invasive surgery worldwide.   

Source Viking Systems, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The BABY1000 study: chasing lifetime risk factors in prenatal and early postnatal life